In the study, Yang et al. [73] found that HOTAIR silencing reduced drug resistance of NSCLC cells to crizotinib by suppressing autophagy via inhibition of ULK1 phosphorylation, with decreased expression of Beclin-1 and LC3 II/I and increased p62 levels. The gene discussed is HOTAIR; the disease is non-small cell lung carcinoma.